HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bijan Rezakhaniha Selected Research

Kidney Neoplasms (Kidney Cancer)

6/2015RETRACTED ARTICLE: The value of U-NGAL expression as a potential prognostic biomarker in patients with renal cancer after neoadjuvant chemotherapy with cisplatin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bijan Rezakhaniha Research Topics

Disease

2Neoplasms (Cancer)
11/2021 - 01/2016
2Premature Ejaculation
04/2021 - 11/2019
1Lower Urinary Tract Symptoms
11/2021
1Dyspepsia (Indigestion)
11/2019
1Varicocele
10/2018
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018
1Carcinogenesis
01/2016
1Renal Cell Carcinoma (Grawitz Tumor)
01/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Nasopharyngeal Carcinoma
08/2015
1Lymphatic Metastasis
08/2015
1Kidney Neoplasms (Kidney Cancer)
06/2015
1Wounds and Injuries (Trauma)
04/2015
1Nocturia
04/2011

Drug/Important Bio-Agent (IBA)

2Biomarkers (Surrogate Marker)IBA
08/2015 - 06/2015
1Uric Acid (Urate)IBA
11/2021
1Sertraline (Zoloft)FDA LinkGeneric
04/2021
1Serotonin (5 Hydroxytryptamine)IBA
11/2019
1Pharmaceutical PreparationsIBA
11/2019
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2018
1AntioxidantsIBA
10/2018
1salicylhydroxamic acid (SHAM)IBA
10/2018
1ChromatinIBA
10/2018
1Interleukin-22 (IL-22)IBA
01/2018
1InterleukinsIBA
01/2018
1Interleukin-17 (Interleukin 17)IBA
01/2018
1ChemokinesIBA
01/2016
1Chemokine ReceptorsIBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
06/2015
1theranekronIBA
04/2015
1Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
04/2011

Therapy/Procedure

1Neoadjuvant Therapy
06/2015
1Aftercare (After-Treatment)
04/2011
1Oral Administration
04/2011